About Cronus Biotech
Cronus Biotech is a Healthcare company. Pharmaceutical formulations, manufacturing, and related medical services in India. Its Indian entity Cronus Biotech Limited reported revenue of ₹70.1 Lakh. Cronus Biotech offers products and services including CROXITE-500 and CROGEST-200 CAP. Its focus areas include Pharmaceuticals, Formulations and Manufacturing, Drug Development and Medical Services.
Company details
Cronus Biotech is recognized as one of the fastest growing pharmaceutical companies in India, with its headquarters located in Ahmedabad, Gujarat. A strong emphasis is placed on social responsibility, where efforts are directed towards addressing societal health concerns beyond commercial objectives. The company is noted for its ISO 9001-2008 certification and compliance with WHO-GMP standards, alongside a portfolio exceeding 200 molecules. Operations extend to formulations, third-party manufacturing, and exports to South Asian nations, while collaborations involve developing new technologies and supporting medical services through affiliated organizations.
- SectorsHealthcare
- Email••••••••
- Legal Name Cronus Biotech Ltd
- Date of Incorporation 08 Jun, 2010
- Jurisdiction Ahmedabad, Gujarat, India
- Indian entity revenue₹70.1 Lakh
FY 2025 · -31% YoY
- Indian entity net profit₹22.2 Lakh
FY 2025 · 32% margin
- Indian entity EBITDA₹22.3 Lakh
FY 2025 · 32% margin
Associated legal entities of Cronus Biotech
Cronus Biotech operates through Cronus Biotech Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cronus Biotech Limited CIN U24100GJ2010PLC061036 | Active | 08 Jun 2010 | Ahmedabad, Gujarat | ₹0.7 Cr | 3 | View details |
Products & Services of Cronus Biotech
Cronus Biotech offers a comprehensive portfolio of products and services, including CROXITE-500 and CROGEST-200 CAP.
This molecule is utilized in formulations for various medical applications, as part of the company's extensive product range.
This product is employed in pharmaceutical treatments, contributing to the company's portfolio of over 200 molecules.
Board of directors of Cronus Biotech Limited (Cronus Biotech)
Cronus Biotech Limited is the primary company behind Cronus Biotech. The board of Cronus Biotech Limited currently have 3 directors; the longest-serving is Mohit Shrawankumar Shah, appointed in 2010. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mohit Shrawankumar Shah DIN 02601871 | Director | 08 Jun 2010 | 16 yrs 4 mo | Cronus Biotech Limited |
| Brijal Bhavin Brahmbhatt DIN 09332850 | Director | 15 Oct 2021 | 5 yrs | Cronus Biotech Limited |
| Muneesh Kumar DIN 09360487 | Director | 15 Oct 2021 | 5 yrs | Cronus Biotech Limited |
Financials of Cronus Biotech
Figures of Cronus Biotech Limited, the primary company behind Cronus Biotech, for FY 2025. Revenue was ₹70.1 Lakh (-31% year on year). Net profit was ₹22.2 Lakh (32% margin). EBITDA was ₹22.3 Lakh (32% margin). Revenue has grown at a compounded annual rate of +824% over three years and +13% over five years.
- ₹70.1 LakhRevenue · FY 2025 · -31% YoY
- ₹22.2 LakhNet profit · 32% margin
- ₹22.3 LakhEBITDA · 32% margin
- ₹15 LakhPaid-up capital
- +824%Revenue CAGR, 3 years
- +13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Cronus Biotech Limited are on its company page.
Detailed financial statements for Cronus Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cronus Biotech
The primary company behind Cronus Biotech, Cronus Biotech Limited, reported revenue of ₹70.1 Lakh for FY 2025, down 31% year on year.
Cronus Biotech is recognized as one of the fastest growing pharmaceutical companies in India, with its headquarters located in Ahmedabad, Gujarat. A strong emphasis is placed on social responsibility, where efforts are directed towards addressing societal health concerns beyond commercial objectives. The company is noted for its ISO 9001-2008 certification and compliance with WHO-GMP standards, alongside a portfolio exceeding 200 molecules. Operations extend to formulations, third-party manufacturing, and exports to South Asian nations, while collaborations involve developing new technologies and supporting medical services through affiliated organizations.
Cronus Biotech offers CROXITE-500 and CROGEST-200 CAP.
Cronus Biotech operates through Cronus Biotech Limited.
The legal entities of Cronus Biotech currently have 3 directors, including Brijal Bhavin Brahmbhatt, Muneesh Kumar, Mohit Shrawankumar Shah.